Inventor
FOLLOWS BRUCE
US28 patents
⚠️ This page may combine multiple inventors who share the name “FOLLOWS BRUCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
20 patentsUS10377773B2Aug 13, 2019
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC18 citations94
US10377767B2Aug 13, 2019
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC16 citations94
US10351571B2Jul 16, 2019
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC15 citations94
US10000495B2Jun 19, 2018
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC21 citations94
US9938300B2Apr 10, 2018
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC23 citations94
US9840491B2Dec 12, 2017
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC22 citations94
US10377760B2Aug 13, 2019
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC17 citations93
US9902728B2Feb 27, 2018
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC24 citations93
US10513507B2Dec 24, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC9 citations92
US9932351B2Apr 3, 2018
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC24 citations92
US10519129B2Dec 31, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC8 citations84
US10519128B2Dec 31, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC8 citations84
US10519130B2Dec 31, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC8 citations84
US10519127B2Dec 31, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC8 citations84
US10513508B2Dec 24, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC8 citations84
US10508098B2Dec 17, 2019
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
FORMA THERAPEUTICS INC8 citations84
US11161848B2Nov 2, 2021
Purinones as ubiquitin-specific protease 1 inhibitors
FORMA THERAPEUTICS INC1 citations73
US10399980B2Sep 3, 2019
Purinones as ubiquitin-specific protease 1 inhibitors
FORMA THERAPEUTICS INC2 citations73
US10189841B2Jan 29, 2019
Purinones as ubiquitin-specific protease 1 inhibitors
FORMA THERAPEUTICS INC3 citations73
US12043623B2Jul 23, 2024
Purinones as ubiquitin-specific protease 1 inhibitors
FORMA THERAPEUTICS INC0 citations62
VALO EARLY DISCOVERY INC
6 patentsUS10836741B2Nov 17, 2020
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
VALO EARLY DISCOVERY INC3 citations84
US10934299B2Mar 2, 2021
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
VALO EARLY DISCOVERY INC7 citations83
US10981915B2Apr 20, 2021
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
VALO EARLY DISCOVERY INC3 citations73
US10927130B2Feb 23, 2021
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
VALO EARLY DISCOVERY INC4 citations73
US10906916B2Feb 2, 2021
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
VALO EARLY DISCOVERY INC4 citations73
US11739071B2Aug 29, 2023
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
VALO EARLY DISCOVERY INC0 citations62